VirtualScopics Competitors and Similar CompaniesClear all
VirtualScopics's competitors and similar companies include Analogic, AKESOgen, Biothera and Akebia Therapeutics.
 VirtualScopics VirtualScopics is a provider of imaging solutions for the pharmaceutical, biotechnology, and medical device industries. |  AKESOgen AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural |  Biothera Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems. | |||
Founding Date | Founding Date 2000 | Founding Date 1967 | Founding Date 2010 | Founding Date 1997 | Founding Date 2007 |
Type | Type Subsidiary | Type Private | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Rochester, US HQ Vienna, AT New Hope, US | Locations Peabody, US HQ Québec, CA Shanghai, CN | Locations Norcross, US HQ | Locations Roseville, US HQ | Locations Cambridge, US HQ |
Employees | Employees 633% decrease | Employees 8711% increase | Employees 6 | Employees 542% increase | Employees 324187% increase |
Funding | |||||
Total funding raised | Total funding raised $ 3m | Total funding raised N/A | Total funding raised $ 1.5m | Total funding raised $ 5.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Analogic
HQ
Peabody, US
Employees
871↑ 1% increase
Analogic is a company that provides medical and security imaging products.
View companyAKESOgen
HQ
Norcross, US
AKESOgen is a biomarker, genomics and pharmacogenomics contract research organization that services the academic, pharmaceutical, biotechnology and agricultural
View companyBiothera
HQ
Roseville, US
Employees
54↑ 2% increase
Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.
View company
Akebia Therapeutics
HQ
Cambridge, US
Employees
324
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company